期刊文献+

氯法拉滨的工艺改进

Improvement of Process of Clofarabine Synthesis
下载PDF
导出
摘要 目的改进氯法拉滨的化学合成路线。方法采用TiCl4的二氯甲烷溶液代替通气(HCl或HBr)处理1-O-乙酰基-2,3,5-三-O-苯甲酰基-β-D-呋喃核糖再加水重排;采用新型的羟基氟代试剂PBSF-Et3N·3HF替代了强腐蚀的硫酰氯等试剂,在温和反应条件下得到1,3,5-二-O-苯甲酰基-2-脱氧-2-氟-α-D-阿拉伯糖(收率86.2%),优化工艺后溴代糖与2-氯嘌呤缩合时β体与α体比例可达19∶1,经氢氧化锂水解得氯法拉滨。结果纯度达到要求,氯法拉滨α体杂质含量小于0.1%,总收率21.2%。结论与文献合成工艺比较,其重排步骤操作简便,氟代反应条件温和、无腐蚀,缩合与水解步骤严格控制了产品质量。 Objective To improve the synthesis process of Clofarabine. Methods 1-O-acetyl-2,3,5-tri-O- benzoyl- β-D-ribofuranose was treated with the solution of WiCl4 in CH2 C12, followed by the addition of water. Instead of extremely corrosive sulfuryl chloride, the rearranged product was fluorinated by novel PBSF-Et3N·3HF to give 1,3,5-di-O-benzoyl- 2-deoxy-2-fluoro-ot-D-arabinose in 86.2% yield. The ratio of the 13 isomer to ot isomer reached 19:1 in the optimized condensation of the brominated arabinose with 2-chloropurine, and the final hydrolysis in methanol by LiOH led to Clorofarabine. Results The total yield of Clofarabine was 21.2%, with the same quality as the reported (α isomer 〈 0.1% ). Conclusion A simple workup, cost-effective process with mild conditions was provided.
出处 《今日药学》 CAS 2013年第11期730-732,739,共4页 Pharmacy Today
基金 福建省区域科技重大项目(编号:2011Y3001)
关键词 氯法拉滨 合成 TICL4 PBSF—Et3N-3HF Clofarabine Synthesis TIC14 PBSF-Et3N- 3HF
  • 相关文献

参考文献15

二级参考文献69

  • 1王蔚,晋展.抗急性白血病新药Clofarabine[J].药学进展,2004,28(7):336-336. 被引量:10
  • 2FDA批准clofarabine用于儿童急性淋巴细胞白血病[J].世界临床药物,2005,26(2):65-65. 被引量:5
  • 3陈莉莉,岑均达.氯法拉滨的合成[J].中国医药工业杂志,2006,37(8):508-510. 被引量:9
  • 4聂颖兰,傅得兴,胡欣,王唯红.新型抗白血病药氯法拉滨[J].中国新药杂志,2007,16(10):821-824. 被引量:9
  • 5夏敏,蒋慧.儿童急性白血病治疗新药氯法拉滨[J].世界临床药物,2007,28(6):356-359. 被引量:11
  • 6JEHA S, GAYNON PS, RAZZOUK BI, et al. Phase Ⅱ study of elofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia [J]. J Clin Oncol, 2006, 24 (12): 1917-1923.
  • 7PUI CH, PEI D, SANDLUND JT, et al. Risk of adverse events after completion of therapy for childhood acute lymphoblastie leukemia [J]. J Clin Oncol, 2005, 23 (31 ) : 7936-7941.
  • 8SADOWITZ PD, SMITH SD, SHUSTER J, et al. Treatment of late bone marrow relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group Study [J]. Blood, 1993, 81(3): 602-609.
  • 9PUI CH, JEHA S, KIRKPATRICK P. Clofarabine [J]. Nat Rev Drug Discov, 2005, 4(5): 369-370.
  • 10GENINI D, ADACHI S, CHAO Q, et al. Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria [J]. Blood, 2000, 96(10): 3537-3543.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部